[go: up one dir, main page]

AR057296A1 - Diarilsulfona sulfonamidas y el uso de las mismas - Google Patents

Diarilsulfona sulfonamidas y el uso de las mismas

Info

Publication number
AR057296A1
AR057296A1 ARP060101934A ARP060101934A AR057296A1 AR 057296 A1 AR057296 A1 AR 057296A1 AR P060101934 A ARP060101934 A AR P060101934A AR P060101934 A ARP060101934 A AR P060101934A AR 057296 A1 AR057296 A1 AR 057296A1
Authority
AR
Argentina
Prior art keywords
arylcarbonyl
alkyl
sulfonyl
heterocycloalkyl
hydrogen
Prior art date
Application number
ARP060101934A
Other languages
English (en)
Inventor
Ariamala Jay Gopalsamy
William Moore
Jeffery Curtis Kern
Albert John Molinari
Mengxiao Scott Shi
Gregory Welmaker
Matthew Allan Wilson
Girija Krishnamurthy
Thomas Joseph Commons
Michael Byron Webb
Richard P Woodwoth
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of AR057296A1 publication Critical patent/AR057296A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3882—Arylalkanephosphonic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C317/20—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of rings other than six-membered aromatic rings of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/14—Sulfones; Sulfoxides having sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C317/22—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C317/32—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C317/34—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring
    • C07C317/38—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring with the nitrogen atom of at least one amino group being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/42—Radicals substituted by singly-bound nitrogen atoms having hetero atoms attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4056—Esters of arylalkanephosphonic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente se refiere a modulares de la proteína rizadasecretada relacionada con la proteína-1. Los compuestos y composiciones, conteniendo dichos compuesto puede ser usados para tratar una variedad de desordenes incluyendo la osteoporosis. Reivindicacion 1: Un compuesto de la formula (1), o una sal farmacéuticamente aceptable de estos, caracterizado porque R1 es un grupo de formulas (2) a (10), y cada grupo R1 es sustituido opcionalmente con más de tres grupos R8; Y es O, S, o NR9; R8 es alquilo, arilalquilo, perfluoroalquilo, alquenilo, arilalquenilo, alquinilo, arilalquinilo, cicloalquilo, alquilcicloalquilo, heterocicloalquilo, alquilheterocicloalquilo, arilo, alquilarilo, heteroarilo, alcoxilo, perfluoroalcoxilo, arilalcoxilo, alquilcarbonilo, arilcarbonilo, halogeno, ciano, azido, hidroxilo, carboxilo, alcoxicarbonilo, alquilamino, dialquilamino, alquilaminocarbonilo, dialquilaminocarbonilo, alquilcarbonilamino, alquilcarbonilalquilamino, hidroxialquilamino, nitro, alquilcarboniloximo, alquilsulfonilo, alquilsulfinilo, alquiltio, perfluoroalquiltio, ariltio, alquilcarbinolo terciario, alquilcicloalquilcarbinolo terciario, o arilalquilcarbinolo terciario; R9 es un hidrogeno, alquilo, arilo, arilalquilo, cicloalquilalquilo, heterocicloalquilo, o espirocicloalquilo; X es un oxígeno o un electron par; R2 es un hidrogeno, alquilo, alcoxilo, cicloalquilo, perfluoroalquilo, perfluoroalquilalquilo, perfluoroalcoxilo, dialquilamino, o un halogeno; R4 es un hidrogeno, halogeno, alquilo, cicloalquilo, alcoxilo, perfluoroalquilo, o perfluoroalcoxilo; o R2 y R4, junto con los átomos de carbono a los cuales ellos son unidos, formando un anillo cicloalquilo de 5 a 7 átomos de carbono que es opcionalmente sustituido con 1 a 3 grupos R; cada R es, un hidrogeno, alquilo, arilalquilo, cianoalquilo, cicloalquilo, cicloalquilalquilo, heterocicloalquilo, espirocicloalquilo, arilo, arilalquilo, o alcoxialquilo independiente; R5, y R6 son, un hidrogeno, alquilo, arilo, alcoxilo, halogeno, o perfluoroalquilo independiente; R3 y R7 son, cada uno hidrogeno u opcionalmente un grupo alquilo, cicloalquilo, heterocicloalquilo, alquilheterocicloalquilo, heteroarilalquilo, alquilarilo, alquilheteroarilo, alquenilo, alquinilo, cicloalquilarilo fusionado, heterocicloalquilarilo fusionado, cicloalquilcarbonilo, o heterocicloalquilcarbonilo sustituido; o R3 y R7, juntas con el átomo de hidrogeno a los cuales van a ser, formando un anillo heterocicloalquilo de 5 o 6 miembros opcionalmente sustituido con 1 a 5 sustituyentes seleccionados desde alquilo, arilo, heterocicloalquilo, heterocicloalquilalquilo, alquilamino, dialquilamino, alcoxicarbonilo, alquilcarbonilo, alquilaminocarbonilalquilo, y heterocicloalquilcarbonilalquilo; proveyendo que el compuesto no sea: 2-metil-N-(2-feniletil)-5-(fenilsulfonil)-benzenosulfonamida; 2-metil-N-(2-fenilmetil)-5-(fenilsulfonil)-benzenosulfonamida; 5-[(4- clorofenil)sulfonil]-N-ciclohexil-2-metilbenzenosulfonamida; N-benzil-5-[(4-clorofenil)sulfonil]-2-metilbenzenosulfonamida; 5-[(4-clorofenil)sulfonil]-N-(2-furilmetil)-2-metilbenzenosulfonamida; 5-[(4-clorofenil)sulfonil]-2-metilbenzenosulfonamida; 2-metil-5-(fenilsulfonil)-benzenosulfonamida; 5-[(4-bromofenil)sulfonil]-2-metilbenzenosulfonamida; 2-metil-5-[(4-nitrofenil)sulfonil]-benzenosulfonamida; 5-[(2,4-dinitrofenil)sulfonil]-2-metil-benzenosulfonamida; o 5-[(4-clorofenil)sulfonil]-2- metil-N-(3-piridinilmetil)-benzenosulfonamida.
ARP060101934A 2005-05-13 2006-05-12 Diarilsulfona sulfonamidas y el uso de las mismas AR057296A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68108005P 2005-05-13 2005-05-13
US11/432,788 US20060276464A1 (en) 2005-05-13 2006-05-10 Diarylsulfone sulfonamides and use thereof

Publications (1)

Publication Number Publication Date
AR057296A1 true AR057296A1 (es) 2007-11-28

Family

ID=37103195

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060101934A AR057296A1 (es) 2005-05-13 2006-05-12 Diarilsulfona sulfonamidas y el uso de las mismas

Country Status (17)

Country Link
US (1) US20060276464A1 (es)
EP (1) EP1879859A2 (es)
JP (1) JP2008540579A (es)
KR (1) KR20080012361A (es)
AR (1) AR057296A1 (es)
AU (1) AU2006247334A1 (es)
BR (1) BRPI0610009A2 (es)
CA (1) CA2607326A1 (es)
CR (1) CR9507A (es)
GT (1) GT200600199A (es)
IL (1) IL187269A0 (es)
NO (1) NO20075781L (es)
PE (1) PE20061451A1 (es)
RU (1) RU2007141346A (es)
SV (1) SV2007002526A (es)
TW (1) TW200719897A (es)
WO (1) WO2006124875A2 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2625378T3 (es) 2005-09-27 2017-07-19 Shionogi & Co., Ltd. Derivado de sulfonamida que tiene actividad antagonista del receptor de PGD2
WO2008061006A1 (en) * 2006-11-10 2008-05-22 Wyeth Substituted indan-2-yl, tetrahydronaphthalen-2-yl, or dihydr0-2h-chr0men-3-yl arylsulfonamides and methods of their use
CL2007003223A1 (es) * 2006-11-10 2008-01-11 Wyeth Corp Compuestos derivados de piperidinil 4-arilsulfonamidas n-sustituidas, que actuan como moduladores de la proteina sfrp-1; proceso para preparar los compuestos; co mposicion farmaceutica que comprende a dichos copmpuestos y uso de los compuestos para preparar medicamentos para el tratamiento de enfermedades.
WO2008060999A1 (en) * 2006-11-10 2008-05-22 Wyeth Piperidinyl arylsulfone derivatives as modulators of secreted frizzled related protein-1
EP1964834A1 (en) * 2007-03-01 2008-09-03 Bayer Schering Pharma Aktiengesellschaft Sulphonyltryptophanols
US20080255117A1 (en) * 2007-03-01 2008-10-16 Lars Wortmann Sulfonyltryptophanols
EP1985612A1 (en) * 2007-04-26 2008-10-29 Bayer Schering Pharma Aktiengesellschaft Arymethylen substituted N-Acyl-gamma-aminoalcohols
CA2694748A1 (en) * 2007-07-13 2009-01-22 Icagen, Inc. Sodium channel inhibitors
CA2705294C (en) * 2007-11-16 2016-05-17 Abbott Laboratories Methods of treating arthritis by the administration of substituted benzenesulfonamides
GB0723794D0 (en) 2007-12-05 2008-01-16 Lectus Therapeutics Ltd Potassium ion channel modulators and uses thereof
EP2617415B1 (en) * 2010-09-16 2016-04-20 Catholic Kwandong University Industry Foundation Use of a compound for inducing differentiation of mesenchymal stem cells into cartilage cells
EP2471363A1 (de) 2010-12-30 2012-07-04 Bayer CropScience AG Verwendung von Aryl-, Heteroaryl- und Benzylsulfonamidocarbonsäuren, -carbonsäureestern, -carbonsäureamiden und -carbonitrilen oder deren Salze zur Steigerung der Stresstoleranz in Pflanzen
BR112016006930A2 (pt) 2013-10-04 2017-08-01 Bayer Cropscience Ag uso de diidrooxindolilsulfonamidas substituídas, ou dos sais destas, para o aumento da tolerância ao estresse de plantas
FR3038324B1 (fr) * 2015-06-30 2020-10-30 Lab Francais Du Fractionnement Procede de cryoconservation de cellules a visee therapeutique
WO2018108627A1 (de) 2016-12-12 2018-06-21 Bayer Cropscience Aktiengesellschaft Verwendung substituierter indolinylmethylsulfonamide oder deren salze zur steigerung der stresstoleranz in pflanzen
WO2019025153A1 (de) 2017-07-31 2019-02-07 Bayer Cropscience Aktiengesellschaft Verwendung von substituierten n-sulfonyl-n'-aryldiaminoalkanen und n-sulfonyl-n'-heteroaryldiaminoalkanen oder deren salzen zur steigerung der stresstoleranz in pflanzen
CN111372579B (zh) 2017-10-30 2023-08-22 神经孔疗法股份有限公司 取代的苯基磺酰基苯基三唑硫酮和其用途
KR102217147B1 (ko) 2019-06-11 2021-02-18 (주)부흥산업사 피페리디닐디페닐술포닐술폰아미드의 제조방법
CN112898178A (zh) * 2021-01-25 2021-06-04 蚌埠产品质量监督检验研究院 一种N-Boc-反式-1,4-环己二胺的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6593M (es) * 1965-10-23 1969-01-06
US4912131A (en) * 1987-06-18 1990-03-27 Merck Frosst Canada, Inc. 4,7-diacyloxybenzofuran derivatives
DE19920790A1 (de) * 1999-05-06 2000-11-09 Bayer Ag Bis-Sulfonamide mit anti-HCMV-Wirkung
US20080166356A9 (en) * 1999-09-13 2008-07-10 Peter Bodine Pharmaceutical compositions and methods of using secreted frizzled related protein
WO2002072570A2 (en) * 2001-03-13 2002-09-19 Schering Corporation Non-imidazole compounds as histamine h3 antagonists
AU2004251754A1 (en) * 2003-06-25 2005-01-06 Elan Pharmaceuticals, Inc. Methods and compositions for treating rheumatoid arthritis

Also Published As

Publication number Publication date
CA2607326A1 (en) 2006-11-23
US20060276464A1 (en) 2006-12-07
WO2006124875A3 (en) 2007-01-18
TW200719897A (en) 2007-06-01
AU2006247334A1 (en) 2006-11-23
WO2006124875A2 (en) 2006-11-23
CR9507A (es) 2008-01-10
KR20080012361A (ko) 2008-02-11
SV2007002526A (es) 2007-12-12
NO20075781L (no) 2008-02-05
BRPI0610009A2 (pt) 2010-05-18
GT200600199A (es) 2007-02-23
JP2008540579A (ja) 2008-11-20
PE20061451A1 (es) 2007-01-22
RU2007141346A (ru) 2009-06-20
EP1879859A2 (en) 2008-01-23
IL187269A0 (en) 2008-02-09

Similar Documents

Publication Publication Date Title
AR057296A1 (es) Diarilsulfona sulfonamidas y el uso de las mismas
RU2386622C2 (ru) Гетероароматические производные мочевины и их применение в качестве активаторов глюкокиназы
RU2401260C2 (ru) Пиримидиновые производные
PE20040600A1 (es) Derivados de triazol como antagonistas del receptor de taquicinina
AR082888A1 (es) Compuestos de piridina para la inhibicion de nampt
AR124973A1 (es) Nuevos derivados de pirimidina-2-il sulfonamida
PE20030200A1 (es) Bencimidazol como inhibidores de las map quinasas
PE20030269A1 (es) Derivados de benzamida tiazol y composiciones farmaceuticas para inhibir la proliferacion de celulas
AR054024A1 (es) Derivados de piridina -3- carboxamida como agonistas inversos de cb1
PE20060361A1 (es) Compuestos heterociclicos como inhibidores de la cinesina mitotica
PE20011047A1 (es) Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas
CO5700754A2 (es) Derivados de piperazina y su uso en el tratamiento de enfermedades neurologicas y psiquiatricas
AR077440A1 (es) Bencenosulfonamidas como bloqueadores de canales de calcio y composiciones farmaceuticas
AR040076A1 (es) Derivados de piridazin-3(2h)-ona
AR035783A1 (es) Compuesto, composicion farmaceutica que lo comprende y su uso en la fabricacion de medicamentos para modular efectos de los receptores de histamina 3
AR072545A1 (es) Fenilpirazinonas como inhibidores de la btk, composicion farmaceutica que las contiene y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades autoinmunes e inflamatorias.
RU2011101774A (ru) Новые замещенные пиридин-2-оны и пиридазин-3-оны
AR037901A1 (es) Beta-amino-alfa-cianoacrilatos
AR069814A1 (es) Derivados de 4 amino-pirimidina, proceso de preparacion y composiciones farmaceuticas que los contienen
AR036366A1 (es) Derivados de piperidina utiles como antagonistas de ccr5, composiciones farmaceuticas, el uso de dichos derivados para la fabricación de un medicamento y un kit
AR068376A1 (es) Amidas heterociclicas utiles para inhibir la via hedgehog.
AR069813A1 (es) Derivados de 2- amino-pirimidina, una composicion farmaceutica, un metodo de preparacion del compuesto y uso del mismo para preparar un medicamento
PE20060483A1 (es) Compuestos heterociclicos como antagonistas de nk1
AR051995A1 (es) Derivados de tieno-piridina como intensificadores alostericos de gaba -b
AR043487A1 (es) Heterociclos fusionados de pirimidina y usos de los mismos

Legal Events

Date Code Title Description
FB Suspension of granting procedure